Navigation Links
New Diarrhoea Bug Warning in Australia

Australia must prepare for the possible outbreak of a highly infectious strain of a diarrhoea-causing organism, scientists have warned in the latest issue// of the Medical Journal of Australia (MJA).

Clostridium difficile (C. difficile) is the most commonly diagnosed cause of infectious hospital-acquired diarrhoea in developed countries, including Australia.

Canada, Europe, and the US have all recently seen sudden increases in rates of C. difficile infection and high mortality rates, with people over 65 years of age being most at risk, suggesting the emergence of a highly virulent strain of C. difficile.

Professor Thomas Riley, Professor in Microbiology and Immunology at the University of Western Australia, outlines the characteristics of the various strains of C. difficile.

"Acquisition of C. difficile is facilitated by its ability to form spores that are resistant to many disinfectants, so that it remains viable in the hospital environment for long periods of time," says Prof Riley.

He adds that C. difficile strains have also shown resistance to one group of antibiotics (fluoroquinolones), possibly through overuse of these medications.

The virulent strain cannot be differentiated from other strains without molecular typing, which makes it difficult to know whether the organism has reached Australia's shores.

He says many laboratories in Australia, to save money and time, are using a testing technology that may not detect the virulent C. difficile strain.

Prof Riley recommends targeted surveillance, with one or two laboratories being funded periodically to test samples from a number of different hospitals.

"The value of sensible policies regarding antibiotic use, and good infection control staff and procedures, cannot be over emphasised," he says.

"In the long term, such initiatives are likely to have an impact not only on C. difficile-associated diarrhoea but also on other infection control problem organisms."


'"/>




Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Deadly Diarrhoea Vaccine – Trail Results Promising
3. Health Department Geared Up To Meet Diarrhoea Cases
4. Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
5. Students of Dharamsala Hospitalized for Diarrhoea
6. Early Warning System For Breast Cancer
7. Warning on radiowave exposure
8. A Seizure Late In Life Could be A Stroke Warning
9. Blood Pressure An Early Warning Sign Of Alzheimer’s Disease
10. Early Warning Signs Of Heart Disease
11. Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... A new study from ... and Medicare rates for a variety of medical services in Illinois as of ... the 2015 Fee Schedule Rates in Illinois, are professional medical services, hospital ...
(Date:2/9/2016)... (PRWEB) , ... February 09, ... ... print and e-book publishing software, in partnership with Snowfall4pod Digital, creators of ... a comprehensive book publishing, content management, global distribution and print-on-demand network. , ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Establishment Labs, ... of Dr. David Hung to the company´s Board of Directors. , “We ... class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of Establishment ...
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain Research has ... field .” , As corresponding author Dr John F. Peppin says “Terminology matters, yet ... our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are replete ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Dr. Rassouli, ... whitening packages. Teeth whitening is among the most popular cosmetic procedures in dentistry today, ... whitening needs. This can put them at risk of teeth whitening-related damage. For a ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... The global prefilled syringes market accounted for $3,905.1 million ... with a CAGR of 12.9% during 2015-2020. Among the ... global prefilled syringes market, with 90.1% share in 2014. ... global market of prefilled syringes is up surging with ... demand for vaccines, increasing prevalence of chronic and lifestyle ...
Breaking Medicine Technology: